2024/08/16 17:44:24 | |
---|---|
Price | |
8.48 EUR | |
Difference | 3.24% (0.27) |
ISIN | ES0171996087 |
Symbol | GRF |
Exchange | BME Continuous Market |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 5,214 EUR |
Benchmark | IBEX 35 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 8.286 EUR |
High | 8.506 EUR |
Low | 8.22 EUR |
Close (prev. day) | 8.214 EUR |
VWAP | 8.408812 EUR |
Volume (pcs) | 1,381,725 |
Trading volume | 11,618,666.04 |
Number of trades | 2,856 |
Last size | 20 |
Related Futures | 36 |
Related Options | - |
Date | Headline | Download | |
2024/08/12 |
![]() |
Global Equity Ratings |
![]() |
2024/07/24 |
![]() |
Global Equity Ratings |
![]() |
2024/07/12 |
![]() |
Global Equity Ratings |
![]() |
2024/06/21 |
![]() |
Global Equity Ratings |
![]() |
2024/06/14 |
![]() |
Global Equity Ratings |
![]() |
2024/08/16 17:44:24 | |
---|---|
Price | |
8.48 EUR | |
Difference | 3.24% (0.27) |
ISIN | ES0171996087 |
Symbol | GRF |
Exchange | BME Continuous Market |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 5,214 EUR |
Benchmark | IBEX 35 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 8.286 EUR |
High | 8.506 EUR |
Low | 8.22 EUR |
Close (prev. day) | 8.214 EUR |
VWAP | 8.408812 EUR |
Volume (pcs) | 1,381,725 |
Trading volume | 11,618,666.04 |
Number of trades | 2,856 |
Last size | 20 |
6m | 1Y | 3Y | |
Perf (%) | -22.01% | -38.11% | -59.50% |
Perf (abs.) | -2.34 | -5.11 | -12.20 |
Beta | 1.50 | 1.90 | 1.14 |
Volatility | 67.57 | 66.33 | 53.36 |
Ø price 5 days | Ø volume 5 days (pcs.) | 8.40 EUR (1,642,495) |
Ø price 30 days | Ø volume 30 days (pcs.) | 9.07 EUR (2,434,849) |
Ø price 100 days | Ø volume 100 days (pcs.) | 9.03 EUR (2,691,248) |
Ø price 250 days | Ø volume 250 days (pcs.) | 10.46 EUR (2,773,764) |
YTD High | date | 15.63 EUR (2024/01/02) |
YTD Low | date | 6.36 EUR (2024/03/06) |
52 Weeks High | date | 15.92 EUR (2023/12/29) |
52 Weeks Low | date | 6.36 EUR (2024/03/06) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Vienna Stock Exchange | 2024/08/16 | 15:30 | 8.368 EUR | 0.00 | 4 |
Tradegate | 2024/08/16 | 18:55 | 8.472 EUR | 0.07 | 22 |
Stuttgart | 2024/08/16 | 16:27 | 8.424 EUR | 0.00 | 10 |
Munich | 2024/08/16 | 08:09 | 8.36 EUR | 0.00 | 1 |
London Stock Exchange European Trade Reporting | 2024/08/16 | 17:30 | 8.438 EUR | 0.00 | 2 |
Hanover | 2024/08/16 | 08:01 | 8.358 EUR | 0.00 | 1 |
Frankfurt | 2024/08/16 | 08:08 | 8.17 EUR | 0.00 | 1 |
FINRA other OTC Issues | 2024/08/15 | 21:06 | 8.65 USD | 0.04 | 1 |
Duesseldorf | 2024/08/16 | 19:31 | 8.442 EUR | 0.00 | 5 |
Berlin | 2024/08/16 | 19:33 | 8.516 EUR | 0.00 | 15 |
BME Continuous Market | 2024/08/16 | 17:44 | 8.48 EUR | 11.62 | 2,856 |
GRIFOLS SA |
- - |
Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan - 08174 Barcelona |
Telefon: +34-93-571-02-21 |
Fax: +34-93-571-02-67 |
E-mail: - |
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain. |
Nacho Abia | Chairman of Managing Board |
Raimon Grifols Roura | Member of Executive Committee |
Thomas Glanzmann | Member of Executive Committee |
Víctor Grífols Deu | Member of Executive Committee |
Thomas Heinrich Glanzmann | Chairman of Supervisory Board |
Enriqueta Felip Font | Member of Supervisory Board |
Albert Coma-Cros | Member of Supervisory Board |
Anne-Catherine Berner | Member of Supervisory Board |
James Costos | Member of Supervisory Board |
Montserrat Muñoz Abellana | Member of Supervisory Board |
Susana González Rodríguez | Member of Supervisory Board |
Tomás Dagá Gelabert | Member of Supervisory Board |
Íñigo Sánchez-Asiaín Mardones | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.
The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.